WAT Stock: Waters Corporation Stock Price, Analysis & Insights
Get live wat stock price $367.34, comprehensive Waters Corporation stock analysis, charts, news, and expert forecast. Real-time wat stock data and investment insights.
Loading chart...
Company Overview
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. Its MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. The company offers thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by life science, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. Waters Corporation was founded in 1958 and is headquartered in Milford, Massachusetts.
Company Information
- CEO
- Udit Batra
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Employees
- 7600
Contact Information
- Website
- https://www.waters.com
- Address
- 34 Maple Street
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 33.8)
Business Model & Strategy
Waters Corporation operates in the Medical - Diagnostics & Research industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO Udit Batra, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Medical - Diagnostics & Research model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
Waters Corporation competes in the Medical - Diagnostics & Research within the broader Healthcare. With 21.9 billion in market capitalization, the company is positioned as a established player in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the New York Stock Exchange, Waters Corporation provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating Waters Corporation should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Waters Corporation shareholders
- ⚠Market volatility can significantly impact stock price, especially for mid-cap stocks
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Waters Corporation
- ⚠Investors should consider how Waters Corporation fits within their overall portfolio allocation
- ⚠Premium valuation (P/E: 33.8) requires strong growth to justify
Market Cap
21.87B
P/E Ratio
33.79
Beta
1.11
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 21.87B market capitalization
- Trading Volume: 1.24M shares traded today
- Price Range: 52-week range of $275.05 - $423.56
- Exchange: Listed on New York Stock Exchange
Financial Metrics
Market Analysis for Waters Corporation
Waters Corporation (WAT) operates in the Medical - Diagnostics & Research industry within the Healthcare sector. With a current market capitalization of 21.87B, the company represents a significant player in its market. The stock is currently trading at $367.34 with a positivedaily change of 6.29%.
The company's 7600 employee base and presence on the New York Stock Exchangeexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of 33.79, beta of 1.11, and 52-week price range from $275.05 to $423.56when evaluating investment opportunities.
Why Invest in Waters Corporation?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (New York Stock Exchange)
- • Experienced leadership under Udit Batra
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.